Answers are grounded in this paper and cite their sources.
Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe post-infectious complication associated with SARS-CoV-2. Neurological manifestations occur in approximately one quarter of MIS-C cases, ranging from mild symptoms such as headache and photophobia to severe complications including seizures, encephalopathy, and stroke. This article provides a comprehensive review of the neurological aspects of MIS-C, incorporating evidence from the literature and a detailed case report of a 15-year-old male who presented with acute neurological symptoms, systemic inflammation, and multiorgan involvement. Four main pathophysiological mechanisms have been proposed to explain neurological involvement: cytokine-mediated neuroinflammation, blood–brain barrier disruption, autoimmune responses, and direct viral neuroinvasion. Neuroimaging and EEG findings often support encephalopathic processes, while laboratory and immunological profiles indicate a hyperinflammatory state. The present case also highlights a potential link between severe hyponatremia and neurological complications. Management strategies—such as immunomodulation, anticoagulation, supportive therapy, and neuroprotective interventions—are discussed in this context. The prognosis for MIS-C patients with neurological involvement varies, with severe cases requiring long-term monitoring. This review underscores the importance of early neurological assessment in MIS-C to guide treatment and improve outcomes.
No takes yet. Share an insight, caveat, or question.
Vasilev et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: